StockDrifts LogoStockDrifts

Nichi-Iko Pharmaceutical Co., Ltd. 4541

Company
日医工株式会社Nichi-Iko Pharmaceutical Co., Ltd.
Investors
5
Buys
6
Total Value
¥16.9B ($109.0M)
Avg Return
+25.72%
Last Filing
2023-04-03

Nichi-Iko Pharmaceutical Co., Ltd. (4541) has 6 disclosed large-shareholding filings and 3 disclosed disposals on record, filed by 5 distinct investors. Together those filings cover ¥16.9B ($109.0M) in reported transaction value. The earliest filing StockDrifts holds for Nichi-Iko Pharmaceutical Co., Ltd. is dated 2021-05-06; the most recent is 2023-04-03. All of it is parsed from EDINET large-shareholding (5%+) reports, the official disclosure system operated by the Financial Services Agency (Japan). Across these filings the average return since disclosure is +25.72%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

DateTypeSourceInsiderPurposeSharesPrice at filingReturnValue
2023-04-03BUYnegotiated
田村 友一
Yuichi Tamura
activist1.8M¥26.79+30.6%¥42M ($274K)
2023-04-03BUYnegotiated
株式会社拓
Taku Co., Ltd.
corporate2.1M¥26.79+30.6%¥51M ($329K)
2023-04-03BUYnegotiated
株式会社TAMURA
TAMURA Co., Ltd.
other4.6M¥26.79+30.6%¥111M ($714K)
2023-03-10BUYacquisition
合同会社ジェイ・エス・ディー
godo kaisha jsd
corporate633.5M¥26.26+33.3%¥16.6B ($107.3M)
2023-03-10BUYacquisition
合同会社ジェイ・エス・ディー
godo kaisha jsd
corporate633.5M¥26.26+33.3%¥16.6B ($107.3M)
2021-12-16BUYnegotiated
株式会社拓
Taku Co., Ltd.
corporate2.1M¥28.15+24.3%¥60M ($385K)
2021-12-16BUYnegotiated
株式会社TAMURA
TAMURA Co., Ltd.
other4.6M¥28.15+24.3%¥129M ($830K)
2021-12-16BUYnegotiated
田村 友一
Yuichi Tamura
activist1.8M¥28.15+24.3%¥50M ($325K)
2021-09-30SELLnegotiated
株式会社拓
Taku Co., Ltd.
corporate2.1M¥30.67-14.1%¥6M ($41K)
2021-09-30SELLnegotiated
株式会社TAMURA
TAMURA Co., Ltd.
other4.6M¥30.67-14.1%¥13M ($85K)
2021-09-30SELLnegotiated
田村 友一
Yuichi Tamura
activist1.8M¥30.67-14.1%¥5M ($34K)
2021-09-02BUYunknown
株式会社メディパルホールディングス
MEDIPAL HOLDINGS CORPORATION
strategic7.0M¥30.46+14.9%¥212M ($1.4M)
2021-05-06BUYnegotiated
株式会社拓
Taku Co., Ltd.
corporate2.1M¥30.66+14.2%¥65M ($420K)
2021-05-06BUYnegotiated
株式会社TAMURA
TAMURA Co., Ltd.
other4.6M¥30.66+14.2%¥400K ($3K)
2021-05-06BUYnegotiated
田村 友一
Yuichi Tamura
activist1.8M¥30.66+14.2%¥55M ($354K)

Frequently asked questions

Who has been buying Nichi-Iko Pharmaceutical Co., Ltd. stock?
5 distinct investors have filed 6 disclosed large-shareholding filings in Nichi-Iko Pharmaceutical Co., Ltd. (4541), most recently on 2023-04-03. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Nichi-Iko Pharmaceutical Co., Ltd. have?
Nichi-Iko Pharmaceutical Co., Ltd. has 6 buy-side and 3 sell-side disclosures on record, covering ¥16.9B ($109.0M) in total reported value, spanning 2021-05-06 to 2023-04-03.
Where does StockDrifts get Nichi-Iko Pharmaceutical Co., Ltd. insider data?
From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.
Do insider buys in Japanese stocks predict returns?
Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Source filings

Every trade listed above is disclosed in EDINET large-shareholding (5%+) reports, filed with the Financial Services Agency (Japan). View the original EDINET filings for Nichi-Iko Pharmaceutical Co., Ltd.. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.